Previous 10 | Next 10 |
home / stock / nriff / nriff news
The U.S. Court of Appeals has denied a rehearing request from Nuvo Pharmaceuticals ( OTCQX:NRIFF ) seeking to reverse its decision invalidating two U.S. patents covering anti-inflammatory med VIMOVO (naproxen/esomeprazole magnesium). More news on: Nuvo Pharmaceuticals Inc., Healthcare st...
MISSISSAUGA, ON , July 30, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI; OTCQX: NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today provided an update regarding its VIMOVO patents. Th...
Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with Deerfield Canada NewsWire MISSISSAUGA, ON, June 26, 2019 MISSISSAUGA, ON , June 26, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo ...
MISSISSAUGA, ON , June 17, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. ("Nuvo" or "the Company") (TSX:NRI; OTCQX:NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today provided a corporate update on various matters ...
The U.S. Court of Appeals for the Federal Circuit has reversed a lower court decision over the alleged infringement by generic competitors of two U.S. patents covering Horizon Therapeutics' ( HZNP -1% ) Vimovo (naproxen/esomeprazole magnesium). More news on: Nuvo Pharmaceuticals I...
Nuvo Pharmaceuticals™ Announces that U.S. Court of Appeals for the Federal Circuit Reverses District Court's Decision Related to Certain Vimovo Patents Canada NewsWire MISSISSAUGA, ON, May 15, 2019 MISSISSAUGA, ON , May 15, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (N...
Nuvo Pharmaceuticals ( OTCQX:NRIFF ): Q1 Net loss of $7.4M. More news on: Nuvo Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Nuvo Pharmaceuticals™ Announces 2019 First Quarter Results Canada NewsWire MISSISSAUGA, ON, May 14, 2019 - Adjusted Total Revenue Increased 278% to $17.1 million - - Adjusted EBITDA Increased 807% to $5.2 million - - Gross Profit Increased 259% to $9.0 million ...
Play Video Day one of the Bloom Burton & Co. Healthcare Investor Conference (BBHIC) has officially wrapped up and the start of the annual show proved to be another roaring success. Now in its eighth ye...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
News, Short Squeeze, Breakout and More Instantly...
Nuvo Research Inc Company Name:
NRIFF Stock Symbol:
OTCMKTS Market:
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire - First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments -...
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ - Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON , Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/...